Hospital System — 2026-11-17 (5 min read)

Getting an Oncology Second Opinion at China's Top Grade 3A Hospitals: DICOM, Pathology & Turnaround

How overseas cancer patients prepare DICOM scans and pathology blocks for multi-disciplinary tumor boards at PUMCH, Ruijin, and SYSU First Affiliated Hospital.

Direct answer

An oncology second opinion with PET-CT and pathology re-review at a top Chinese Grade 3A international wing costs $1,400 to $2,800 USD and takes 3 to 5 days on-site—or can start with a remote specialist review before booking flights.

What records to prepare before contacting a hospital or coordinator

Chinese oncology chief physicians rely on raw diagnostic files rather than summary letters alone. Before traveling, collect original DICOM imaging files (CT, MRI, PET-CT), biopsy pathology reports (plus unstained slides if re-staining is needed), molecular/genetic mutation panels, and a chronological treatment log.

Having records translated into clinical Chinese ahead of arrival cuts on-site diagnostic delays by 2 to 4 days and allows remote pre-triage to confirm whether surgery, targeted therapy, or proton therapy is viable.

Remote review vs. in-person MDT tumor board

For patients uncertain whether travel is worthwhile, several facilitators arrange a remote document review with a Grade 3A department chair in 5 to 7 working days before you commit to flights.

If you travel in person, international wings can coordinate updated PET-CT imaging within 48 hours and convene a Multi-Disciplinary Team (MDT) consultation uniting surgical oncology, medical oncology, and radiology.

Common questions

Are modern targeted therapies and immunotherapies available in Chinese Grade 3A hospitals?
Yes. Major Grade 3A cancer centers in Beijing, Shanghai, and Guangzhou stock both international originator drugs and domestically approved targeted/PD-1 therapies, often at significantly lower out-of-pocket costs than US retail pricing.

Related hospitals in this guide